FCFrancesca A. Chaloner

Francesca A. Chaloner

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francesca A. Chaloner has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Mallach

    UK Dementia Research Institute, Imperial College London, UK

    1 shared publication
  • Carol Lee Wilkinson

    Division of Developmental Medicine, Boston Children's Hospital, Boston, MA

    1 shared publication
  • Carola I. Radulescu

    UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK

    1 shared publication
  • Cigdem Gelegen

    Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK

    1 shared publication
  • Craig A. Erickson

    Division of Child and Adolescent Psychiatry, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA

    1 shared publication
  • Francesca Osso

    UK Dementia Research Institute Centre, Department of Brain Sciences, Imperial College London, Hammersmith Hospital Campus, London, UK

    1 shared publication

Latest Publications

  • Open Access

    Selective weakening of population-coupled synaptic activity in vivo in a mouse model of amyloid-beta pathology

    by Leire Melgosa-Ecenarro, Carola I. Radulescu, Nazanin Doostdar, Joe Airey, Francesca A. Chaloner, Nawal Zabouri, Giada Pedretti, Francesca Osso, Leire Garrido Perez, Kjara S. Pilch, et al.

    Synaptic dysfunction in Alzheimer’s disease (AD) may drive synapse loss and cognitive impairment. Whether AD-related synaptic pathophysiology occurs globally, or in specific synapses, is unclear. We investigate in vivo AD-related synaptic dysfunction during early-stage amyloidosis in App NL-G-F mice. We find reduced presynaptic GABAergic proteins at c-Fos-positive excitatory neurons and increased calcium-mediated activity at excitatory and inhibitory neuronal assemblies. In vivo synaptic structure/function imaging finds reduced density and calcium-mediated activity of GABAergic axonal boutons. Rather than occurring globally, reduced synaptic activity is focused at GABAergic boutons strongly coupled to population activity in the amyloid microenvironment. The selective weakening of population-coupled synaptic activity also occurs in excitatory dendritic spines. Spatial transcriptomics finds parvalbumin-positive inhibitory neurons show differential gene expression associated with downregulated GABAergic synaptic transmission at early stages. We propose that early-stage AD-related synaptic pathophysiology is focused at population-coupled synapses, with molecular measures implicating abnormal synaptic processing as an early-stage feature in parvalbumin-positive interneurons.


  • Open Access

    A human electrophysiological signature of Fragile X pathophysiology is shared in V1 of Fmr1-/y mice

    by Sara S. Kornfeld-Sylla, Cigdem Gelegen, Jordan E. Norris, Francesca A. Chaloner, Maia Lee, Michael Khela, Maxwell J. Heinrich, Peter S. B. Finnie, Lauren E. Ethridge, Craig A. Erickson, et al.

    Predicting clinical therapeutic outcomes from animal studies using conserved electrophysiological phenotypes could facilitate developing treatments for neuropsychiatric disorders. Alpha oscillations in human resting-state electroencephalogram recordings are altered in many disorders, but whether these disruptions exist in mouse models is unknown. Here, we employed a uniform analytical method to show in males with fragile X syndrome (FXS) that alpha oscillations in humans and alpha-like oscillations in the visual cortex of Fmr1 -/y mice are slowed, with a stronger phenotype in adults than juveniles and a juvenile-specific power phenotype in both species. We find that alpha-like oscillations are disrupted by deletion of Fmr1 in cortical excitatory neurons and glia, reflect differential activity of two classes of GABAergic interneurons, and are more sensitive to activation of GABA B receptors by Arbaclofen in wild-type than Fmr1 -/y mice. Our framework reveals evolutionary conservation of alpha oscillation disruptions, enables a deeper understanding of FXS pathophysiology, and narrows the gap between treatment promise and practice.